Showing results (141-150 of 462) with videos related to

Sort By:
Pageof 47
Frontiers in Pharmacology|February 10, 2012
Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant CancersToshiyuki Matsunaga, Yasuhiro Wada, Satoshi Endo, et al.
Chemico-Biological Interactions|February 27, 2003
Identification of amino acid residues involved in substrate recognition of L-xylulose reductase by site-directed mutagenesisShuhei Ishikura, Tomoya Isaji, Noriyuki Usami, et al.
Biochemical and Biophysical Research Communications|April 8, 2020
Dimeric dihydrodiol dehydrogenase is an efficient primate 1,5-anhydro-D-fructose reductaseAkira Hara, Toru Nishinaka, Naohito Abe, et al.
Life Sciences|July 5, 2016
Cynaropicrin is dual regulator for both degradation factors and synthesis factors in the cartilage metabolismTeruaki Masutani, Yuka Tsuda Tanaka, Hiroyuki Kojima, et al.
Biological & Pharmaceutical Bulletin|November 5, 2010
Rat aldose reductase-like protein (AKR1B14) efficiently reduces the lipid peroxidation product 4-oxo-2-nonenalSatoshi Endo, Toshiyuki Matsunaga, Anna Fujita, et al.
Medical Molecular Morphology|December 29, 2017
Expression analyses of Dusp22 (Dual-specificity phosphatase 22) in mouse tissuesNanako Hamada, Makoto Mizuno, Hiroyuki Tomita, et al.
Chemico-Biological Interactions|May 16, 2009
Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human endothelial cellsToshiyuki Matsunaga, Marina Arakaki, Tetsuro Kamiya, et al.
Chemico-Biological Interactions|November 21, 2012
Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancersToshiyuki Matsunaga, Aki Hojo, Yumi Yamane, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|April 17, 2012
Structure of the His269Arg mutant of the rat aldose reductase-like protein AKR1B14 complexed with NADPHKrithika Sundaram, Satoshi Endo, Toshiyuki Matsunaga, et al.
Pageof 47